Abstract:Objective: We aimed to evaluate early-life epilepsy incidence, seizure types, severity, risk factors, and treatments among survivors of acute neonatal seizures. Methods: Neonates with acute symptomatic seizures born 7/2015-3/2018 were prospectively enrolled at nine Neonatal Seizure Registry sites. One-hour EEG was recorded at age three months. Post-neonatal epilepsy and functional development (Warner Initial Developmental Evaluation of Adaptive and Functional Skills - WIDEA-FS) were assessed. Cox regression was used to assess epilepsy-free survival. Results: Among 282 infants, 37 (13%) had post-neonatal epilepsy by 24-months [median age of onset 7-months (IQR 3-14)]. Among those with post-neonatal epilepsy, 13/37 (35%) had infantile spasms and 12/37 (32%) had drug-resistant epilepsy. Most children with post-neonatal epilepsy had abnormal neurodevelopment at 24-months (WIDEA-FS >2SD below normal population mean for 81% of children with epilepsy vs 27% without epilepsy, RR 7.9, 95% CI 3.6-17.3). Infants with severely abnormal neonatal EEG background patterns were more likely to develop epilepsy than those with mild/moderate abnormalities (HR 3.7, 95% CI 1.9-5.9). Neonatal EEG with ≥3 days of seizures also predicted hazard of epilepsy (HR 2.9, 95% CI 1.4-5.9). In an adjusted model, days of neonatal EEG-confirmed seizures (HR 1.4 per day, 95% CI 1.2-1.6) and abnormal discharge examination (HR 3.9, 95% CI 1.9-7.8) were independently associated with time to epilepsy onset. Abnormal (vs. normal) three-month EEG was not associated with epilepsy. Significance: In this multicenter study, only 13% of infants with acute symptomatic neonatal seizures developed post-neonatal epilepsy by age 24-months. However, there was a high risk of severe neurodevelopmental impairment and drug-resistant seizures among children with post-neonatal epilepsy. Days of EEG-confirmed neonatal seizures was a potentially modifiable epilepsy risk factor. An EEG at three months was not clinically useful for predicting epilepsy. These practice changing findings have implications for family counseling, clinical follow-up planning, and future research to prevent post-neonatal epilepsy.

Factor Analysis of Complex Febrile Seizures of Childhood Developing to Epilepsy

Analysis of children epilepsy with history of febrile convulsion

Risk factors for secondary epilepsy following febrile seizures in children: A meta-analysis

Generation of Febrile Seizures and Subsequent Epileptogenesis

Complex Febrile Seizures: Usual and the Unusual

Risk Factors for Febrile Seizures in Children Under 5 at a Tertiary Care Teaching Hospital

Epilepsy Frequency and Risk Factors Three Years After Neonatal Seizures

A case-controlled study of the risk factors for status epilepticus in children

Analysis on clinical characteristic and influencing factors of the first febrile convulsion in 298 children

The Long-Term Neurodevelopmental Outcomes of Febrile Seizures and Underlying Mechanisms

Clinical Characteristics of 27 Children with Febrile Infection‐related Epilepsy Syndrome in a Single Center

Febrile seizures in the developing brain result in persistent modification of neuronal excitability in limbic circuits

[Long-Term Outcome and Related Factors of Epileptic Seizures in Children].

Familial aggregation of status epilepticus in generalized and focal epilepsies

[Clinical Analysis of 15 Patients with Epileptic Spasms and Focal Seizures As a Single Ictal Event in Neonatal Period].

New locus for febrile seizures with absence epilepsy on 3p and a possible modifier gene on 18p

Febrile seizures and childhood epilepsy and risk of internalizing and psychotic symptoms

No association between ApoE polymorphism and febrile seizures

Early-life epilepsy after acute symptomatic neonatal seizures: A prospective multicenter study

Clinical and EEG features of various types of status epilepticus in childhood

Outcome of Absence Epilepsy With Onset at 8-11 Years of Age: Watershed Ages When Syndromes Overlap